Aspirin for thromboembolic prophylaxis emerging from the uncertain world of observational evidence

1 July

Written By Krista Verlis

Harris IA, Sidhu VS, MacDessi SJ, Solomon M, Haddad FS.

Aspirin for thromboembolic prophylaxis. Bone Joint J. 2024;106-B(7):642-645. doi:10.1302/0301-620X.106B7.BJJ-2024-0621

MusculoskeletalPrescribingHipKneeSurgery

Krista Verlis

Randomized Noninferiority Trial to Compare Enteral to Parenteral Phosphate Replacement on Biochemistry, Waste, Enviro Impact & Healthcare Cost in Critically Ill Patients With Hypophosphatemia*

Prioritisation of clinical trial learning needs of musculoskeletal researchers: an inter-disciplinary modified Delphi study by the Australia & New Zealand musculoskeletal clinical trials network